Drug firms facing challenging times due to price control: Cipla
Drug companies are facing a tough environment due to the government bringing more products under the price control policy as also tightening of registration procedure that has impacted time to market newer products, Cipla Chairman YK Hamied has said.
Sep 29, 2016, 16:04 PM IST
Cipla, Godrej recognised in Fortune 'Change the World' list
India's pharmaceutical giant Cipla and consumer goods conglomerate Godrej have been recognised by Fortune magazine in a list of global firms changing the world for the good and having a positive social impact through their activities.
Aug 19, 2016, 14:50 PM IST
Cipla, Godrej Consumer Products in Fortune 'Change the World' list
Two Indian companies -- Cipla and Godrej Consumer Products -- have been named in Fortune magazine's list of top 50 companies that are addressing global social problems as part of their core business strategy.
Aug 18, 2016, 22:00 PM IST
Lupin Pharmaceuticals is India's most reputed pharma brand; Sun Pharma second
Mumbai-based Lupin Pharmaceuticals is India`s most reputed pharmaceutical brand, said a report by Bluebytes, a leading media-analytics company on Wednesday.
Aug 17, 2016, 19:47 PM IST
FDCs banned over safety & efficacy concerns: Centre tells HC
The hearing in the matter would continue on April 4.
Apr 01, 2016, 00:41 AM IST
Delhi High Court to resume hearing on petitions against Centre's ban on drugs
Delhi High Court is likely to resume today the hearing on petitions by over 30 pharmaceutical majors, including Pfizer, Glenmark, Procter and Gamble (P&G) and Cipla, challenging the government's decision to ban sale of some of their fixed dose combination medicines.
Mar 21, 2016, 07:32 AM IST
Cipla invests additional $ 3mn in US's Chase Pharmaceuticals
Drug firm Cipla Ltd has made an additional investment of USD 3 million in US-based Chase Pharmaceuticals engaged in developing novel approaches to improve treatments for Alzheimer's disease.
Mar 16, 2016, 13:33 PM IST
Antim Baazi: Action In Cairn India, Reliance & Cipla
Check out the action going in Cairn India, Reliance & Cipla.
Jan 19, 2016, 00:12 AM IST
Cipla sets up 6-member leadership team
Drug major Cipla on Thursday announced the creation of a 6-member 'Management Council' that will be the apex executive leadership team for the company.
Jan 07, 2016, 23:53 PM IST
Cipla launches generic hepatitis C drug in India
Drug major Cipla has launched generic tablets used for treating of hepatitis C under the brand name 'Hepcvir-L' costing Rs 25,000 for a bottle of 28 tablets in India.
Dec 21, 2015, 18:02 PM IST
Hot Stocks: Expert on Gabriel India, Cipla
Know what our expert has to say about
Cipla infringing Roche's patent in lung cancer drug: HC
In a setback to Cipla, the Delhi High Court on Friday held that the Indian drug major was infringing Swiss pharmaceutical company Hoffman-La Roche's patent in lung cancer drug erlotinib hydrochloride, sold under the name of Tarceva.
Nov 28, 2015, 00:22 AM IST
Cipla to sell entire stake in Biomab Holding for $25,775,000
Drug major Cipla has entered into an agreement to sell its entire stake in Biomab Holding to Biomab Brilliant Ltd for a consideration of USD 25,775,000 to focus on biological segment under its arm Cipla BioTec.
Oct 29, 2015, 20:28 PM IST
Cipla's Indore plant under USFDA scanner over norms violations
Pharmaceutical major Cipla's shares dropped by 2.13 percent Tuesday amid speculation that the company's Indore plant has come under the scanner of US health regulator for manufacturing norms violations.
Oct 20, 2015, 18:31 PM IST
FIPB to take up 25 FDI proposals on Sept 22
FIPB will take up 25 foreign direct investment (FDI) proposals, including those of Aditya Birla Nuvo, Cipla, Sun Pharma Advanced Research and HDFC Capital Advisors, on September 22.
Sep 10, 2015, 16:03 PM IST
Cipla gains 3% on strong revenue outlook
Shares of Cipla Friday soared nearly 3 percent in morning trade on bourses after the company said it expects 20 percent growth in revenues in the current fiscal.
Aug 28, 2015, 11:54 AM IST
Cipla Q1 net profit zooms over two-fold to Rs 651 crore
Drug major Cipla on Friday reported an over two-fold jump in its consolidated net profit to Rs 650.61 crore for the quarter ended June 30, 2015 mainly on account of robust sales.
Aug 14, 2015, 19:48 PM IST
FIL Capital to invest in Cipla's consumer healthcare biz
Drug major Cipla on Tuesday said its board has approved a potential investment by FIL Capital Investments (Mauritius) II Ltd in its consumer healthcare business.
Jul 21, 2015, 11:19 AM IST
Cipla heir apparent Kamil Hamied quits, bigger role for sister Samina
Pharmaceuticals major Cipla Chairman Yusuf K Hamied's nephew Kamil Hamied, who has been understood to be groomed to take over the reins of the drug maker, has quit and his sister Samina Vaziralli has assumed an expanded role in the company.
Jun 24, 2015, 18:31 PM IST
Cipla gets USFDA nod for Lopinavir, Ritonavir oral pellets
The company stock closed at Rs 634.90, down 0.95 per cent, on the BSE.
Jun 03, 2015, 17:06 PM IST
